Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × abemaciclib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 30 Neoplasm Metastasis 7 Brain Neoplasms 6 Prostatic Neoplasms 4 Neoplasms 4 Glioma 4 Glioblastoma 3 Endometrial Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Unilateral Breast Neoplasms 2 Triple Negative Breast Neoplasms 2 Sarcoma, Ewing 2 Recurrence 2 Ovarian Neoplasms 2 Neoplasms by Site 2 Meningioma 2 Colorectal Neoplasms 2 Breast Diseases 2 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Kaposi 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms, Squamous Cell 1

Interventions

Cisplatin 8 Pemetrexed 7 Carboplatin 4 Platinum 3 Nivolumab 3 Ipilimumab 3 1,2-diaminocyclohexaneplatinum II citrate 3 tremelimumab 2 pembrolizumab 2 durvalumab 2 Cyclophosphamide 2 methoxyamine 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 cediranib 1 bintrafusp alfa protein, human 1 atezolizumab 1 aldesleukin 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Pharmaceutical Preparations 1 Interleukin-2 1 In Situ Hybridization, Fluorescence 1 Imprint II 1 Immunoglobulin G 1 Gemcitabine 1 Etoposide 1 Disulfides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡